Eric Hollander MD FACNP, DFAPA

Child & Adolescent Psychiatry, Neuropsychiatry, Psychopharmacology

Professor of Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine; Director - Autism and Obsessive Compulsive Spectrum Program, and Director - Anxiety and Depression Research Program; Psychiatry Research Institute of Montefiore Einstein (PRIME); Attending Lenox Hill Hospital; Director-Spectrum Neuroscience and Treatment Institute

Join to View Full Profile

901 Fifth AvenueNew York, NY 10021
Phone+1 212-873-4051
Fax+1 917-261-5215

Summary

Dr. Eric Hollander is a psychiatrist based in New York, NY, with subspecialties in Neuropsychopharmacology and Neuropsychiatry, and treats children and adults. He completed his education and training at esteemed institutions, including New York-Presbyterian Hospital-Columbia University and the Icahn School of Medicine at Mount Sinai, among others. Dr. Hollander currently serves as a Professor of Psychiatry at Albert Einstein College of Medicine and holds multiple director roles, including at the Autism and Obsessive Compulsive Spectrum Program at the Montefiore Einstein Psychiatry Research institute, and the Spectrum Neuroscience and Treatment Institute. His areas of expertise include autism spectrum disorders, obsessive-compulsive related disorders, impulse control disorders and anxiety disorders. Dr. Hollander has an extensive publication record on topics such as neurodevelopmental disorders and anxiety. He has received various honors, including being named a fellow by the American College of Neuropsychopharmacology and a distinguished fellow by the American Psychiatric Association.

Education & Training

New York-Presbyterian HospitalFellowship, Research, Psychopharmacology, Anxiety Disorders, 1986 - 1989
New York State Psychiatric InstituteResearch, Psychopharmacology, Anxiety Disorders, 1986 - 1989
New York Presbyterian Hospital (Columbia Campus)Fellowship, Consultation-Liaison Psychiatry, 1987 - 1988
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Psychiatry, 1983 - 1986
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1982 - 1983
State University of New York Downstate Medical Center College of MedicineClass of 1982
Brandeis UniversityB.A., 1978
Brandeis UniversityB.A., 1978

Certifications & Licensure

NY State Medical License 1983 - 2027
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Fellow American College of Neuropsychopharmacology
Distinguished Fellow American Psychiatric Association
Best Doctors Castle Conelly, 2000-2015
Best Doctors New York Magazine, 2000-2015
New York Magazine: Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors Castle Connolly, 2002-2014
Distinguished Investigator Award NARSAD, 2009
Best Doctors New York Magazine, and Castle Conelly, 2009-2011
President International Society for Research In Impulsivity (ISRI), 2007
Best Doctors in America 2007, 2009
Best Mental Health Specialists in the U.S.A. Good Housekeeping, 1994
Rafaelsen Fellowship Award Collegium Internationale Neuro-Psychopharmacologium, 1990
Neuro-Psychopharmacologium Rafaelsen Fellowship Award Collegium Internationale, 1990
Young Psychiatrist Research Award, First Place American Psychiatric Association/Wisnieski, 1990
Wisnieski Young Psychiatrist Research Award, First Place American Psychiatric Association, 1990
Research Scientist Development Award National Institute of Mental Health, 1988
Fellow Dana Foundation (Columbia University), 1988
Dana Foundation Fellow Columbia University, 1988
Penwalt Resident Research Award, First Place American Psychiatric Association, 1986
Marcel Heiman Memorial Award for Outstanding Research, Department of Psychiatry Mount Sinai School of Medicine, 1986
M. Ralph Kaufman Prize, Outstanding Resident in Psychiatry, Department of Psychiatry Mount Sinai School of Medicine, 1986
M. Ralph Kaufman Prize, Outstanding Resident in Psychiatry Mount Sinai School of Medicine, 1986
Marcel Heiman Memorial Award for Outstanding Research Mount Sinai School of Medicine, 1986
Resident Research Award, First Place American Psychiatric Association/Penwalt, 1986
Solomon W. Ginsburg Fellow Group for the Advancement of Psychiatry, 1985
Fellow Academia, Medicina & Psychiatria Foundation
Best Doctors NY Magazine
Fellow World General Medical Council
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Study of Fluoxetine in Adults With Autistic Disorder Start of enrollment: 2001 Sep 01
Completed
Not Applicable
Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
COMPLETED
PHASE2
Divalproex Sodium ER in Adult Autism Start of enrollment: 2005 Apr 01
Completed
Phase 4
CBT as an Adjunct to SRIs in the Treatment of BDD Start of enrollment: 2008 Sep 01
Terminated
Phase 4
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD) Start of enrollment: 2004 Nov 01
Terminated
Topiramate in the Treatment of Pathological Gambling Start of enrollment: 2005 Oct 01
Terminated
Phase 3
Fluoxetine in Pediatric Body Dysmorphic Disorder Start of enrollment: 2004 Nov 01
Completed
Phase 4
Efficacy of Escitalopram in the Treatment of Internet Addiction Start of enrollment: 2002 Dec 01
Completed
Phase 4
Trichuris Suis Ova in Autism Spectrum Disorders Start of enrollment: 2012 Nov 01
Completed
Phase 1
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Start of enrollment: 2011 Jan 01
Terminated
Phase 2
Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders Start of enrollment: 2009 Oct 01
Completed
Not Applicable
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism Start of enrollment: 2011 Feb 01
Completed
Phase 4
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression Start of enrollment: 2012 May 01
Unknown status
Not Applicable
Hyperthermia and the Amelioration of Autism Symptoms Start of enrollment: 2012 Nov 01
Completed
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Start of enrollment: 2014 May 01
Terminated
Phase 2
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2014 Aug 01
Completed
Not Applicable
A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) Start of enrollment: 2015 May 13
Completed
Phase 3
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Start of enrollment: 2018 Apr 11
COMPLETED
PHASE2
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2019 Apr 12
RECRUITING
PHASE2
CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) Start of enrollment: 2020 Nov 23
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome.
Alyssa Josselsohn, Yin Zhao, Danielle Espinoza, Eric Hollander
Pharmacology & Therapeutics. 2024-12-01
1 citations
An update from the WPA Section on Anxiety and Obsessive-Compulsive Disorders.
Naomi A Fineberg, Dan J Stein, Katharina Domschke, Eric Hollander, Susanne Walitza
World Psychiatry. 2024-10-01
1 citations
Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder: Factor Structure and Construct Validity of Subfactors.
Ivar Snorrason, Adam C Jaroszewski, Jennifer L Greenberg, Hilary Weingarden, Berta J Summers
Journal of Obsessive-Compulsive and Related Disorders. 2024-07-01

Journal Articles

In Search of Biomarkers for Autism Spectrum Disorder
Eric Hollander, James T McCracken, Autism Research
Manifesto for a European research network into obsessive-compulsive and related disorders
Van Ameringen M, Simpson W, Patterson B, Dell'osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H,..., Eur Neuropsychopharmacol, 1/1/2013
Guidelines for the pharmacological treatment of axiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Moller HJ, WFSBP Task Force on Mental Disorders in Primary Care; WPSBP Task Force on Anxiety Disorder..., Int J Psychiatry Clin Pract, 1/1/2012
Low-frequnecy rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response,
Pallanti S, Di Rollo A, Antonini S, Cauli G, Hollander E, Quercioli L, Neuropsychobiology, 1/1/2012
A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders
Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C, Am J Psychiatry, 1/1/2012
Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders
Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A, J Autism Dev Disord, 1/1/2012
A double-blind, placebo-controlled trial of topiramate for pathological gambling
Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E, World J Biol Psychiatry, 1/1/2011
The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB
Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E, Psychiatry Res, 1/1/2011
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study (Erratum)
Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW, Br J Psychiatry, 1/1/2011
In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism
Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J, Brain Res, 1/1/2011
Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder
Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E, J Clin Psychiatry, 1/1/2011
Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees
Hankin CS, Koran L, Sheehan DV, Hollander E, Culpepper L, Black DW, Knispel J, Dunn J, Dougherty DD, Bronstone A, Wang Z, Ann Clin Psychiatry, 1/1/2011
Novel treatment options of binge eating disorder
Marazziti D, Rossi L, Baroni S, Consoli G, Hollander E, Catena-Dell'osso M, Curr Med Chem, 1/1/2011
Development and validation of the appearance and performance enhancing drug use schedule
Hildebrandt T, Langenbucher JW, Lai JK, Loeb KL, Hollander E, Addict Behav, 1/1/2011
Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment
Fineberg N, Chamberlain S, Hollander E, Boulougouris V, Robbins T, Br J Pharmecol, 1/1/2011
Oxytocin administration attenuates stress reactivity in borderline personality disorder: A pilot study
Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S, Hollander E, Psychoneuroendocrinology, 1/1/2011
Oxytocin can hinder trust and cooperation in borerline personality disorder
Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E, Soc Cogn Affect Neurosci, 1/1/2011
Factor analysis of repetitive behaviors in Autism as measured by the Y-BOCS
Anagnostou E, Chaplin W, Watner D, Silverman JM, Smith CJ, Zagursky K, Kryzak LA, Corwin TE, Feirsen N, Tanel N, Hollander E, J Neuropsychiatry Clin Neurosci, Summer, 1/1/2011
Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study
Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT, Hollander E, Anagnostou E, PLoS One, 1/1/2011
Serotonin functionin pathological gambling: blunted growth hormone response to Sumatriptan
Pallanti S, Bernardi S, Allen A, Hollander E, J Psychopharmacol, 1/1/2010
Probing compulsitve and impulsive behaviors, from animal models to endophenotypes: a narrative review
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E, Neuropsychopharmacology, 1/1/2010
Relationship between whole blood serotonin and repetitive behaviors in autism
Kolevzon A, Newcorn JH, Kryzak L, Chaplin W, Watner D, Hollander E, Smith CJ, Cook EH Jr, Silverman JM, Psychiatry Res, 1/1/2010
Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder
Dell’Osso B, Buoli M, Hollander E, Altamura AC, World J Biol Psychiatry, 1/1/2010
Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder
Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E, Compr Psychiatry, 1/1/2010
Autism and oxytocin: new developments in translational approaches to therapeutics
Green JJ, Hollander E, Neurotherapeutics, 1/1/2010
Join now to see all

Books/Book Chapters

Autism Spectrum Disorders
Chapter: Comorbid Obsessive-Compulsive Disorders.
Page 270 - 284Taylor BP, HollanderOxford University Press2011
Obsessive-Compulsive Spectrum Disorders: Refining the Research Agenda for DSM-V.
Editors: Hollander E, Zohar J, Sirovatka PJ, Regier DA.American Psychiatric Association, Arlington, VA2011
Textbook of Autism Spectrum Disorders.
Hollander E, Kolevzon A, Coyle JAmerican Psychiatric Publishing, Inc., Washington, DC2010
Textbook of Anxiety Disorders
Stein DJ, Hollander E, Rothbaum BAmerican Psychiatric Publishing, Inc., Washington, DCEdition 2nd,2009
Advances In Vasopressin and Oxytocin—From Genes to Behaviour To Disease, Progress In Brain Research (Volume 170)
Chapter: Oxytocin and experimental therapeutics in autism spectrum disorders.
Page 451 - 462Bartz JA, Hollander EEditors: Neumann ID, Landgraf R.Elsevier, Oxford2008
American Psychiatric Publishing Textbook of Psychiatry
Chapter: Anxiety disorders.
Page 505 - 607Hollander E, Simeon DAmerican Psychiatric Publishing, Washington, DCEdition 5th,2008
The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences
Chapter: Neuropsychiatric aspects of aggression and impulse control disorders.
Page 535 - 565Hollander E, Berlin HAEditors: Yudofsky SC and Hales RE.American Psychiatric Publishing, Inc., Washington, DCEdition 5th,2008
Handbook of Psychiatric Measures
Chapter: Impulse-control disorders measures.
Page 667 - 686Hollander E, Berlin HAEditors: Rush AJ, First MB, Blacker D.American Psychiatric Publishing, Inc, Artlington, VAEdition 2nd,2008
American Psychiatric Publishing Textbook of Psychiatry
Chapter: Impulse control disorders not elsewhere classified.
Page 777 - 820Hollander E, Berlin, HA, Stein, DJAmerican Psychiatric Publishing, Washington, DCEdition 5th,2008
Clinical Manual for the Treatment of Autism.
Editors: Hollander E, Anagnostou E.American Psychiatric Publishing, Inc., Washington, DC2007
Clinical Manual of Impulse Control Disorders.
Chapter: Conceptualizing and assessing impulse-control disorders.
Page 1 - 18Hollander E, Baker BR, Kahn J, Stein DJEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
Clinical Manual of Impulse Control Disorders.
Chapter: Sexual compulsions.
Page 87 - 114Allen A, Hollander EEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
Clinical Manual of Impulse Control Disorders.
Chapter: Pathological gambling.
Page 251 - 289Pallanti S, Baldini Rossi N, Hollander EEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
Clinical Manual of Impulse Control Disorders.
Chapter: Treatment of impulse-control disorders.
Page 309 - 325Stein DJ, Harvey B, Seedat S, Hollander EEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
Textbook of Suicide Assessment and Management
Chapter: Anxiety disorders.
Page 313 - 332Simeon D, Hollander EEditors: Simon RI, Hales RE.American Psychiatric Publishing, Washington, DC2006
Essentials of Clinical Psychopharmacology
Chapter: Treatment of Personality Disorders.
Page 689 - 705Simeon D, Hollander EEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Washington, DCEdition 2nd,2006
Progress in Neurotherapeutics and Neuropsychopharmacology, Vol 1
Chapter: Liquid Fluoxetine versus placebo for repetitive behaviors in childhood autism.
Hollander E, Swanson E, Anagnostou E, Phillips A, Chaplin W, Wasserman SCambridge University Press, Cambridge, United Kingdom2006
Clinical Manual of Impulse Control Disorders.
Editors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
Coping with Social Anxiety: The Definitive Guide to Effective Treatment Options.
Editors: Hollander E, Bakalar N.Henry Holt and Company, New York, NY2005
Somatoform Disorders, Volume 9
Chapter: Advancing the understanding of dysmorphic disorder.
Hollander E, Dell’osso BEditors: Maj M, Akiskal HS, Mezzich J, Okasha A.Wiley Publishing, Inc., NJ2005
Pathological Gambling: A Clinical Guide to Treatment
Chapter: Pharmacological Treatments.
Page 189 - 205Hollander E, Kaplan A, Pallanti SEditors: Grant JE, Potenza MN.American Psychiatric Publishing, Inc., Washington, DC2004
Essentials of Clinical Psychiatry
Chapter: Anxiety disorders.
Page 339 - 422Hollander E, Simeon DEditors: Hales RE and Yudofsky SC.American Psychiatric Publishing, Arlington, VAEdition 2nd,2004
American Psychiatric Publishing Textbook of Psychopharmacology
Chapter: Treatment of personality disorders.
Hollander E, Simeon DEditors: Schatzberg AF and Nemeroff CB.American Psychiatric Publishing, Inc., Arlington, VAEdition 3rd,2004
Tratado de los Trastornos de Ansiedad.
Editors: Stein DJ, Hollander E.Ars Medica, Barcelona, Spain2004
Autism Spectrum Disorders
Chapter: Core symptoms, related disorders, and course of autism.
Page 15 - 38Hollander E, Nowinski CVEditors: Hollander E.Marcel Dekker, Inc., New York, NY2003
Join now to see all

Other

Comorbid social anxiety disorder and body dysmorphic disorder.
Hadley SJ, Greenberg J, Hollander E, Anxiety and Depression (STAND)
www.depression.org
1/1/2002
Insuring a sound financial future for the ACNP.
Hollander E, ACNP Bulletin

Press Mentions

Oryzon Defines Phase III Trial Endpoints for Agitation and Aggression in BPD with Input from New Clinical Advisory BoardMarch 3rd, 2025
SMI Adviser to Bring Hands-on Learning to Annual MeetingMarch 28th, 2023
Going on Trial: Orphan Drugs; CBD; BumetanideFebruary 28th, 2023
Join now to see all